Please login to the form below

Not currently logged in

amyloid plaque

This page shows the latest amyloid plaque news and features for those working in and with pharma, biotech and healthcare.

Lilly’s anti-amyloid antibody donanemab renews Alzheimer’s hopes

Lilly’s anti-amyloid antibody donanemab renews Alzheimer’s hopes

This unique mechanism and antibody for clearing plaques, discovered at Lilly, has the potential to provide high levels of durable amyloid plaque clearance after limited duration dosing," said Daniel Skovronsky,   chief ... Another amyloid-targeting

Latest news

More from news
Approximately 1 fully matching, plus 13 partially matching documents found.

Latest Intelligence

  • Interview: Jan Lundberg, Eli Lilly Interview: Jan Lundberg, Eli Lilly

    also an oral agent to implant the amyloid pathway that is planned to go into phase II this year. ... We also have an upcoming diagnostic opportunity in Alzheimer's: an imaging agent that can be used to detect amyloid plaque in the living human brain,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...